Drawing for HEMOPOC

USPTO serial 79289214

HEMOPOC

Reviewed by CopyMark Law Group

Reg. 6366865Status 700Renewal
Filing date
Status date
Registration date
Jun 1, 2021
Examiner
HOLTZ, ALLISON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEMOPOC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Zhi Dong

Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of colorectal diseases and colorectal cancer; biological preparations for medical purposes for the treatment of colorectal diseases and colorectal cancer; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes for the treatment of colorectal diseases and colorectal cancer; enzyme preparations for medical purposes; nutritive substances for microorganisms for medical purposesACTIVE—
010Apparatus for use in medical analysis, namely, apparatus for analyzing blood, body fluid and excrement, and medical diagnostic apparatus for analyzing and measuring tumour cells in the blood, body fluid and excrement samples; testing apparatus for medical purposes, namely, testing apparatus for blood, body fluid and excrement, and medical diagnostic apparatus for testing DNA and RNA samples, tumour cells testing apparatus for medical use; diagnostic apparatus for medical purposes, namely, diagnostic apparatus for the detection and screening of tumors, and medical diagnostic apparatus for testing tumor cells and DNA; blood testing apparatus; hemocytometers; sphygmomanometers; respirators for artificial respiration; apparatus for artificial respiration; dropper bottles for administering medication, sold empty; medical apparatus and instruments, namely, medical apparatus and instruments for monitoring characteristic of blood, body fluid and excrement, medical apparatus and instruments for treating cancers, medical apparatus and instruments for preventing or reversing cancers, medical apparatus and instruments for measuring and displaying tumour cells in the blood, body fluid and excrement samplesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 1, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 25, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 23, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 23, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 1, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 1, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 16, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 16, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2021GPNXNOTIFICATION PROCESSED BY IB—
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 24, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 11, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 11, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 11, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 11, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 10, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 10, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 10, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2021LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Jan 19, 2021LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Sep 27, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 6, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 1, 2020RFRRREFUSAL PROCESSED BY MPU—
Aug 4, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 3, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2020DOCKASSIGNED TO EXAMINER—
Jul 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance